Terms: = Cervical cancer AND AKT1, P31749, RAC-ALPHA, RAC, PRKBA, PKB-ALPHA, PKB, MGC99656, AKT, ENSG00000142208, 207 AND Staging
15 results:
1. Comprehensive analysis of clinical prognosis and biological significance of CNIH4 in cervical cancer.
Wang J; Wang S; Wang J; Huang J; Lu H; Pan B; Pan H; Song Y; Deng Q; Jin X; Shi G
Cancer Med; 2023 Dec; 12(24):22381-22394. PubMed ID: 38087815
[TBL] [Abstract] [Full Text] [Related]
2. Identification and validation of serum tumor-markers based nomogram to predict the prognostic value of patients with cervical adenocarcinoma.
Liu Y; Shi L; Chen K; Ye W
Curr Probl Cancer; 2022 Dec; 46(6):100899. PubMed ID: 36270166
[TBL] [Abstract] [Full Text] [Related]
3. [
Zheng J; Liu F; Lin K; Zhang L; Huang N; Zheng W; Zhang J; Yao S; Miao W
Mol Imaging Biol; 2022 Dec; 24(6):973-985. PubMed ID: 35945360
[TBL] [Abstract] [Full Text] [Related]
4. Stearoyl-CoA desaturase 1 regulates malignant progression of cervical cancer cells.
Wang L; Ye G; Wang Y; Wang C
Bioengineered; 2022 May; 13(5):12941-12954. PubMed ID: 35609330
[TBL] [Abstract] [Full Text] [Related]
5. UBE2C Drives Human cervical cancer Progression and Is Positively Modulated by mTOR.
Chiang AJ; Li CJ; Tsui KH; Chang C; Chang YI; Chen LW; Chang TH; Sheu JJ
Biomolecules; 2020 Dec; 11(1):. PubMed ID: 33396624
[TBL] [Abstract] [Full Text] [Related]
6. Increased ZNF84 expression in cervical cancer.
Li P; Guo H; Zhou G; Shi H; Li Z; Guan X; Deng Z; Li S; Zhou S; Wang Y; Wang S
Arch Gynecol Obstet; 2018 Jun; 297(6):1525-1532. PubMed ID: 29610946
[TBL] [Abstract] [Full Text] [Related]
7. MicroRNA-409 inhibits the proliferative ability of cervical carcinoma cells by regulating akt.
Li B; Wu N; Zhang XJ; Wei ZL; Shang LX
Eur Rev Med Pharmacol Sci; 2018 Feb; 22(4):936-942. PubMed ID: 29509241
[TBL] [Abstract] [Full Text] [Related]
8. Long Noncoding RNA GAS5, Which Acts as a Tumor Suppressor via microRNA 21, Regulates Cisplatin Resistance Expression in cervical cancer.
Wen Q; Liu Y; Lyu H; Xu X; Wu Q; Liu N; Yin Q; Li J; Sheng X
Int J Gynecol Cancer; 2017 Jul; 27(6):1096-1108. PubMed ID: 28472815
[TBL] [Abstract] [Full Text] [Related]
9. Minimally invasive surgical management of early-stage cervical cancer: an analysis of the risk factors of surgical complications and of oncologic outcomes.
Garabedian C; Merlot B; Bresson L; Tresch E; Narducci F; Leblanc E
Int J Gynecol Cancer; 2015 May; 25(4):714-21. PubMed ID: 25647258
[TBL] [Abstract] [Full Text] [Related]
10. Factors predicting nodal metastasis in endometrial cancer.
Gilani S; Anderson I; Fathallah L; Mazzara P
Arch Gynecol Obstet; 2014 Dec; 290(6):1187-93. PubMed ID: 24981050
[TBL] [Abstract] [Full Text] [Related]
11. Roles of galectin-7 and S100A9 in cervical squamous carcinoma: Clinicopathological and in vitro evidence.
Zhu H; Wu TC; Chen WQ; Zhou LJ; Wu Y; Zeng L; Pei HP
Int J Cancer; 2013 Mar; 132(5):1051-9. PubMed ID: 22864818
[TBL] [Abstract] [Full Text] [Related]
12. Radical hysterectomy for early stage cervical cancer: laparoscopy versus laparotomy.
Taylor SE; McBee WC; Richard SD; Edwards RP
JSLS; 2011; 15(2):213-7. PubMed ID: 21902978
[TBL] [Abstract] [Full Text] [Related]
13. Predictive factors related to the recurrence at US-guided fine needle aspiration in postoperative patients with differentiated thyroid cancer.
Hahn SY; Shin JH; Han BK; Ko EY; Kang SS; Chung JH; Kim JH; Oh YL; Son YI
Clin Endocrinol (Oxf); 2011 Feb; 74(2):270-5. PubMed ID: 21044120
[TBL] [Abstract] [Full Text] [Related]
14. Laparoscopic assisted parametrectomy/upper vaginectomy (LPUV)-technique, applications and results.
Fleisch MC; Hatch KD
Gynecol Oncol; 2005 Sep; 98(3):420-6. PubMed ID: 16005499
[TBL] [Abstract] [Full Text] [Related]
15. [Laparoscopic hysterectomy in the surgical treatment of gynecological malignant and premalignant diseases].
Maffuz-Aziz A; Cortés-Martínez G; Delgado-Ramírez R; Escudero-de los Ríos P; Quijano-Castro F; López-Hernández D
Cir Cir; 2005; 73(2):107-12. PubMed ID: 15910703
[TBL] [Abstract] [Full Text] [Related]
